NASDAQ:SURF - Surface Oncology News Headlines

$2.71
-0.03 (-1.09 %)
(As of 07/22/2019 12:00 PM ET)
Today's Range
$2.70
Now: $2.71
$2.77
50-Day Range
$2.52
MA: $3.10
$3.91
52-Week Range
$2.47
Now: $2.71
$14.80
Volume3,384 shs
Average Volume100,679 shs
Market Capitalization$75.45 million
P/E RatioN/A
Dividend YieldN/A
Beta2.42

Headlines

Surface Oncology (NASDAQ SURF) News Headlines

Source:
DateHeadline
Surface Oncology Inc (NASDAQ:SURF) Short Interest UpdateSurface Oncology Inc (NASDAQ:SURF) Short Interest Update
www.americanbankingnews.com - July 11 at 8:48 PM
Surface Oncology to Participate in 40th Annual Goldman Sachs Global Healthcare ConferenceSurface Oncology to Participate in 40th Annual Goldman Sachs Global Healthcare Conference
finance.yahoo.com - June 7 at 7:55 PM
Surface Oncology Presents Preclinical Data Further Supporting Anti-Tumor Mechanism of CD73 and CD39 Programs at Brisbane Immunotherapy 2019Surface Oncology Presents Preclinical Data Further Supporting Anti-Tumor Mechanism of CD73 and CD39 Programs at Brisbane Immunotherapy 2019
finance.yahoo.com - May 24 at 11:44 AM
Surface Oncology to Present at Two Upcoming Healthcare ConferencesSurface Oncology to Present at Two Upcoming Healthcare Conferences
finance.yahoo.com - May 15 at 9:09 PM
Surface Oncology beats by $0.29, beats on revenueSurface Oncology beats by $0.29, beats on revenue
seekingalpha.com - May 9 at 11:48 AM
Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2019Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2019
finance.yahoo.com - May 9 at 11:48 AM
Surface Oncology, Inc. (SURF) Reports Q1 Loss, Tops Revenue EstimatesSurface Oncology, Inc. (SURF) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 9 at 11:48 AM
Surface Oncology Management to Present at the Solebury Trout Class of 2018 Biotech IPOs Investor DaySurface Oncology Management to Present at the Solebury Trout Class of 2018 Biotech IPOs Investor Day
finance.yahoo.com - April 24 at 11:51 AM
Surface Oncology Announces Appointment of Wendy Dwyer as Chief Business OfficerSurface Oncology Announces Appointment of Wendy Dwyer as Chief Business Officer
finance.yahoo.com - April 1 at 1:12 PM
Surface Oncology Inc.Surface Oncology Inc.
www.barrons.com - March 29 at 12:27 PM
Surface Oncology to Present at the 39th Annual Cowen Healthcare ConferenceSurface Oncology to Present at the 39th Annual Cowen Healthcare Conference
finance.yahoo.com - March 15 at 12:15 PM
Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2018Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2018
globenewswire.com - March 8 at 12:21 PM
Could Surface Oncology, Inc.’s (NASDAQ:SURF) Investor Composition Influence The Stock Price?Could Surface Oncology, Inc.’s (NASDAQ:SURF) Investor Composition Influence The Stock Price?
finance.yahoo.com - February 21 at 1:29 PM
BRIEF-Surface Oncology Says Novartis Elected To Not Purchase Option For Antibody Srf388BRIEF-Surface Oncology Says Novartis Elected To Not Purchase Option For Antibody Srf388
www.reuters.com - February 5 at 10:25 AM
Surface Oncology Retains Worldwide Rights for its First-in-Class Antibody Targeting IL-27, SRF388Surface Oncology Retains Worldwide Rights for its First-in-Class Antibody Targeting IL-27, SRF388
finance.yahoo.com - February 5 at 10:25 AM
Publication in ImmunoHorizons Highlights the Role of IL-27 in Upregulation of Multiple Checkpoint ProteinsPublication in ImmunoHorizons Highlights the Role of IL-27 in Upregulation of Multiple Checkpoint Proteins
finance.yahoo.com - January 17 at 1:17 PM
Kill the Cancer Stem Cell, Kill the Cancer: How One Biotech is Hitting Cancer at the CauseKill the Cancer Stem Cell, Kill the Cancer: How One Biotech is Hitting Cancer at the Cause
finance.yahoo.com - January 10 at 3:35 PM
Surface Oncology Announces Appointment of F. Stephen Hodi, MD to its Scientific Advisory BoardSurface Oncology Announces Appointment of F. Stephen Hodi, MD to its Scientific Advisory Board
finance.yahoo.com - January 4 at 9:28 AM
Surface Oncology Added to the NASDAQ Biotechnology IndexSurface Oncology Added to the NASDAQ Biotechnology Index
finance.yahoo.com - December 21 at 11:03 AM
BRIEF-Surface Oncology resets portfolio priorities, extends cash runway through 2021BRIEF-Surface Oncology resets portfolio priorities, extends cash runway through 2021
www.msn.com - December 19 at 11:16 AM
Surface Oncology shuffles pipeline; cash runway extended; shares down 16% after hoursSurface Oncology shuffles pipeline; cash runway extended; shares down 16% after hours
seekingalpha.com - December 19 at 11:16 AM
Surface Oncology Resets Portfolio Priorities, Extends Cash Runway Through 2021Surface Oncology Resets Portfolio Priorities, Extends Cash Runway Through 2021
finance.yahoo.com - December 19 at 11:16 AM
Surface Oncology Promotes Jessica Fees to Senior Vice President, Finance and Business OperationsSurface Oncology Promotes Jessica Fees to Senior Vice President, Finance and Business Operations
finance.yahoo.com - December 17 at 11:12 AM
Surface Oncology Announces Upcoming Investor PresentationsSurface Oncology Announces Upcoming Investor Presentations
finance.yahoo.com - November 20 at 10:17 AM
Surface Oncology Reports Financial Results and Corporate Highlights for Third Quarter 2018Surface Oncology Reports Financial Results and Corporate Highlights for Third Quarter 2018
finance.yahoo.com - November 13 at 9:55 AM
Next Generation ExacTrac Broadens Clinical WorkflowsNext Generation ExacTrac Broadens Clinical Workflows
www.businesswire.com - October 21 at 3:30 PM
Sensei Biotherapeutics to Present Clinical Data at Upcoming Oncology Medical ConferencesSensei Biotherapeutics to Present Clinical Data at Upcoming Oncology Medical Conferences
www.bizjournals.com - October 10 at 9:14 AM
Can Pfizer (PFE) Bank on Bavencio for Long-Term Growth?Can Pfizer (PFE) Bank on Bavencio for Long-Term Growth?
www.zacks.com - September 18 at 8:33 AM
MPM Capital Expands its Team of Executive Partners and Entrepreneurs with the Appointments of Biotech Leaders Detlev Biniszkiewicz and Scott ChappelMPM Capital Expands its Team of Executive Partners and Entrepreneurs with the Appointments of Biotech Leaders Detlev Biniszkiewicz and Scott Chappel
www.businesswire.com - September 13 at 8:44 AM
BeiGene to Present Data on Anti-PD-1 Antibody Tislelizumab at the IASLC 19th World Conference on Lung Cancer (WCLC) in TorontoBeiGene to Present Data on Anti-PD-1 Antibody Tislelizumab at the IASLC 19th World Conference on Lung Cancer (WCLC) in Toronto
www.streetinsider.com - September 6 at 8:33 AM
Minomic Secures Key Patent in the United States and ChinaMinomic Secures Key Patent in the United States and China
www.businesswire.com - September 5 at 8:37 AM
Surface Oncology to Present at the Baird 2018 Global Healthcare ConferenceSurface Oncology to Present at the Baird 2018 Global Healthcare Conference
finance.yahoo.com - August 30 at 3:21 PM
IPO Biotech Preview: Gritstone OncologyIPO Biotech Preview: Gritstone Oncology
seekingalpha.com - August 27 at 3:22 PM
Targeting the CD47-SIRPA Axis in Oncology, 2018: A Competitive Assessment of Technologies, Dual Targeting, Biomarkers, Combination Therapies & More - ResearchAndMarkets.comTargeting the CD47-SIRPA Axis in Oncology, 2018: A Competitive Assessment of Technologies, Dual Targeting, Biomarkers, Combination Therapies & More - ResearchAndMarkets.com
www.businesswire.com - August 23 at 8:20 AM
Surface Oncology Q2 revenues down 61%Surface Oncology Q2 revenues down 61%
seekingalpha.com - August 14 at 3:20 PM
Call for Pharmaceutical Benefits Scheme to include subsidies for more rare cancer treatmentsCall for Pharmaceutical Benefits Scheme to include subsidies for more rare cancer treatments
www.msn.com - August 14 at 7:57 AM
Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2018Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2018
finance.yahoo.com - August 14 at 7:57 AM
Surface Oncology (SURF) Says FDA Granted Orphan Drug Designation to its SRF231 for Treatment of Multiple MyelomaSurface Oncology (SURF) Says FDA Granted Orphan Drug Designation to its SRF231 for Treatment of Multiple Myeloma
www.streetinsider.com - July 31 at 7:24 AM
FDA Grants Orphan Drug Designation to Surface Oncologys SRF231 for the Treatment of Multiple MyelomaFDA Grants Orphan Drug Designation to Surface Oncology's SRF231 for the Treatment of Multiple Myeloma
www.marketwatch.com - July 31 at 7:24 AM
Surface Oncologys SRF231 an Orphan Drug for multiple myelomaSurface Oncology's SRF231 an Orphan Drug for multiple myeloma
seekingalpha.com - July 30 at 3:21 PM
FDA Grants Orphan Drug Designation to Surface Oncology’s SRF231 for the Treatment of Multiple MyelomaFDA Grants Orphan Drug Designation to Surface Oncology’s SRF231 for the Treatment of Multiple Myeloma
finance.yahoo.com - July 30 at 3:21 PM
Form 3 Surface Oncology, Inc. For: Jul 23 Filed by: Nogelo Liisa IForm 3 Surface Oncology, Inc. For: Jul 23 Filed by: Nogelo Liisa I
www.streetinsider.com - July 25 at 7:24 AM
Company Profile: Surface OncologyCompany Profile: Surface Oncology
seekingalpha.com - July 22 at 3:22 PM
iTeos Therapeutics Appoints Scott Chappel as Chief Scientific OfficeriTeos Therapeutics Appoints Scott Chappel as Chief Scientific Officer
globenewswire.com - July 3 at 8:41 AM
Goodwin dominates this year’s record batch of Mass. biotech IPOsGoodwin dominates this year’s record batch of Mass. biotech IPOs
finance.yahoo.com - July 3 at 8:41 AM
Surface Oncology Recognized as one of the “Best Places to Work” by Boston Business JournalSurface Oncology Recognized as one of the “Best Places to Work” by Boston Business Journal
finance.yahoo.com - June 21 at 3:18 PM
Kaskela Law LLC Announces Investigation of Surface Oncology, Inc. on Behalf of StockholdersKaskela Law LLC Announces Investigation of Surface Oncology, Inc. on Behalf of Stockholders
finance.yahoo.com - June 20 at 3:20 PM
Surface Oncology clears resistance, up 14%Surface Oncology clears resistance, up 14%
seekingalpha.com - June 18 at 3:18 PM
Stocks Keep Paring Losses, But Dow Jones Still Lags As This Chipmaker TumblesStocks Keep Paring Losses, But Dow Jones Still Lags As This Chipmaker Tumbles
finance.yahoo.com - June 18 at 3:18 PM
Surface Oncology announces the launch of an early-stage study of SRF373Surface Oncology announces the launch of an early-stage study of SRF373
seekingalpha.com - June 12 at 3:17 PM
This page was last updated on 7/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel